Woodline Partners’s Signify Health, Inc. SGFY Stock Holding History

Woodline Partners’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-397,000	Closed	-$11.4M	–	881
2022 Q4	$11.4M	Sell	397,000 -233,300	-37%	-$6.73M	0.15%	189
2022 Q3	$18.4M	Buy	630,300 +278,514	+79%	+$6.42M	0.26%	115
2022 Q2	$4.86M	Buy	351,786 +8,535	+2%	+$120K	0.07%	268
2022 Q1	$6.23M	Buy	343,251 +331,281	+2,768%	+$4.75M	0.1%	223
2021 Q4	$170K	Hold	11,970	–	–	﹤0.01%	591
2021 Q3	$214K	Buy	+11,970	New	+$308K	﹤0.01%	572

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Woodline Partners's SGFY Position: Q1 2023 in Review

Woodline Partners sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 397,000 shares — an estimated $11.4M sold.

Woodline Partners first reported a position in SGFY in Q3 2021 and held it in 6 quarters. The position peaked at $18.4M in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

Woodline Partners reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
Woodline Partners sold 397,000 Signify Health, Inc. shares in Q1 2023, an estimated $11.4M.
Woodline Partners first reported a position in Signify Health, Inc. in Q3 2021 and held it in 6 quarters.
Woodline Partners's Signify Health, Inc. position peaked at $18.4M in Q3 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.